Fundraising Fox

Daniel van den Bergh

Investor

Senior Associate at Kaiser Permanente Ventures

San Francisco, California

Writes $7M – $15M checks Β· typically $10M

About

Daniel joined Kaiser Permanente Ventures in 2017 and has about two decades of experience in healthcare venture capital, venture-backed operations, and investment banking. He previously led the US Digital Health practice at Endeavour Vision, held a strategy and operations role at Lumiata, and worked at Safeguard Scientifics, Citigroup, and EC Mergers & Acquisitions; he holds an MBA from Wharton and a BS from Cornell.

ContactΒ· self-published, not guessed

Invests in

Digital HealthHealthtech

Experience

  1. Kaiser Permanente VenturesSenior Investment Directorcurrent2024 β€” presentSan Francisco Bay Area
  2. Kaiser Permanente Ventures--2022 β€” 2024
  3. Kaiser Permanente VenturesInvestment Director2021 β€” 2022San Francisco Bay Area
  4. Kaiser Permanente VenturesPrincipal2019 β€” 2021San Francisco Bay Area
  5. Kaiser Permanente VenturesSenior Associate2017 β€” 2019San Francisco Bay Area
  6. SureCoInvestor, Board Directorcurrent2025 β€” present
  7. NOCDInvestor, Board Observercurrent2021 β€” present
  8. ValidicBoard Director2017 β€” 2026
  9. HealthJoyInvestor, Board Observer2022 β€” 2024
  10. Endeavour VisionSenior Investment Director2022 β€” 2024
  11. Ordr Inc.Investor, Board Observer2020 β€” 2022
  12. NuvoloInvestment Team, Board Director2019 β€” 2022
  13. Vesta HealthcareInvestment Team2019 β€” 2022
  14. NextHealth TechnologiesInvestment Team2019 β€” 2022
  15. ProtenusInvestment Team, Board Director2017 β€” 2022
  16. TalixInvestment Team, Board Observer2018 β€” 2021
  17. Collective MedicalInvestment Team2017 β€” 2020
  18. LumiataDirector, Strategy & Operations2016 β€” 2017San Francisco Bay Area
  19. LumiataSenior Manager, Head of Projects2015 β€” 2016San Francisco Bay Area
  20. Longitude CapitalMBA Associate2014Menlo Park, California, United States
  21. Safeguard ScientificsAssociate, Healthcare Venture Capital2011 β€” 2013Greater Philadelphia Area
  22. EC Mergers & AcquisitionsAssociate, Healthcare M&A2010 β€” 2011New York City Metropolitan Area
  23. EC Mergers & AcquisitionsSenior Analyst, Healthcare M&A2009 β€” 2010New York, New York, United States
  24. Citigroup Global MarketsAnalyst, Investment Banking2007 β€” 2009London Area, United Kingdom
  25. Lux CapitalSummer Analyst2006New York, New York, United States

Skills & more

Digital HealthHealthcare Information Technology (HIT)HealthcareGrowth CapitalVenture CapitalInvestmentsSoftware as a Service (SaaS)

Languages English Β· French

From Daniel's professional profile.

Investments

Investor

Collective MedicalGingerHealth CatalystLeiter’sNextHealthnocdNuvoloOrdrProtenusSurecoTalixVesta Healthcare

Per the firm's website.

Colleagues at Kaiser Permanente Ventures

Network1

Investors connected to Daniel in public investor directories β€” a warm-intro map.

Frequently asked questions

Who is Daniel van den Bergh?
Daniel joined Kaiser Permanente Ventures in 2017 and has about two decades of experience in healthcare venture capital, venture-backed operations, and investment banking. He previously led the US Digital Health practice at Endeavour Vision, held a strategy and operations role at Lumiata, and worked at Safeguard Scientifics, Citigroup, and EC Mergers & Acquisitions; he holds an MBA from Wharton and a BS from Cornell.
Where does Daniel van den Bergh work?
Daniel van den Bergh is Senior Associate at Kaiser Permanente Ventures.
What does Daniel van den Bergh invest in?
Daniel van den Bergh invests in Digital Health, Healthtech.
What check size does Daniel van den Bergh write?
Daniel van den Bergh typically writes checks of $7M – $15M.
What companies has Daniel van den Bergh invested in?
Investments tracked here include Collective Medical, Ginger, Health Catalyst, Leiter’s, NextHealth, nocd, Nuvolo, Ordr, Protenus, Sureco, Talix, Vesta Healthcare.
Where did Daniel van den Bergh go to school?
Daniel van den Bergh studied at The Wharton School (MBA, Health Care Management & Entrepreneurial Management); Cornell University (BS, Biological Engineering & Applied Economics).

Same school

Shared employers